MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ALGS has $109,764K in assets. $37,931K in debts. $41,946K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
470.44%
Cash Ratio
190.78%
Debt to Asset Ratio
34.56%
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Total, at cost
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued liabilities
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
41,946 18,661
Restricted cash
110 110
Short-term investments
57,150 104,284
Other current assets
4,229 4,889
Total current assets
103,435 127,944
Operating lease right-of-use assets
3,581 4,059
Total, at cost
14,490 -
Accumulated depreciation
12,455 -
Property and equipment, net
2,035 2,063
Other assets
713 640
Total assets
109,764 134,706
Accounts payable
4,651 3,937
Accrued liabilities
13,605 12,209
Operating lease liabilities, current
3,542 3,502
Finance lease liabilities, current
21 38
Deferred revenue, current
168 579
Total current liabilities
21,987 20,265
Operating lease liabilities, net of current portion
2,380 3,216
Finance lease liabilities, net of current portion
122 122
2023 common warrants liability
13,396 9,191
Long term liability
46 46
Total liabilities
37,931 32,840
Common stock, 0.0001 par value 115,800,000 shares and 20,800,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 6,153,507 and 3,864,436 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
9 9
Additional paid-in capital
693,689 692,220
Accumulated deficit
-622,320 -590,783
Accumulated other comprehensive income
455 420
Total stockholders' equity (deficit)
71,833 101,866
Total liabilities and stockholders' equity (deficit)
109,764 134,706
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Total, at cost$14,490K Other current assets$4,229K Short-term investments$57,150K Restricted cash$110K Cash and cashequivalents$41,946K Other assets$713K Property and equipment,net$2,035K Operating leaseright-of-use assets$3,581K Total current assets$103,435K Accumulated depreciation$12,455K Total assets$109,764K Total liabilities andstockholders' equity...$109,764K Total stockholders'equity (deficit)$71,833K Total liabilities$37,931K Accumulated deficit-$622,320K Accumulated othercomprehensive income$455K Additional paid-in capital$693,689K Long term liability$46K 2023 common warrantsliability$13,396K Finance leaseliabilities, net of current...$122K Operating leaseliabilities, net of current...$2,380K Total currentliabilities$21,987K Common stock, 0.0001par value...$9K Deferred revenue,current$168K Finance leaseliabilities, current$21K Operating leaseliabilities, current$3,542K Accrued liabilities$13,605K Accounts payable$4,651K

Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics, Inc. (ALGS)